Top compounds associated with response to IRF7


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel UHNBreast pan-cancer AAC 0.23 0.5
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.025 0.5
mRNA MI-1 CTRPv2 pan-cancer AAC 0.027 0.5
mRNA pluripotin CTRPv2 pan-cancer AAC 0.024 0.5
mRNA Nilotinib FIMM pan-cancer AAC -0.12 0.5
mRNA CH5424802 GDSC1000 pan-cancer AAC 0.024 0.5
mRNA masitinib GDSC1000 pan-cancer AAC -0.023 0.5
mRNA 17-AAG FIMM pan-cancer AAC 0.12 0.5
mRNA BI-2536 FIMM pan-cancer AAC -0.088 0.5
mRNA azacitidine CTRPv2 pan-cancer AAC -0.026 0.5
Download CSV